Your browser is no longer supported. Please, upgrade your browser.
XBI SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-0.29%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month8.71%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter2.77%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio4.35 Perf Half Y6.84%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year40.92%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range46.36 - 69.92 Perf YTD14.53%
Dividend0.17 P/FCF- EPS past 5Y- ROI- 52W High-4.29% Beta-
Dividend %0.25% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low44.35% ATR1.37
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)56.20 Volatility2.19% 2.07%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.75 Prev Close67.79
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.48M Price66.92
Recom- SMA201.24% SMA505.03% SMA2009.81% Volume931,408 Change-1.28%
Feb-21-17 08:09AM  The case for buying the biotech bounce at CNBC
Feb-17-17 11:34AM  Biotech ETF Investors are Still on the Sidelines at Investopedia
07:44AM  Biotech Stock Mailbag: Bulls Love a Distracted Trump, Protalix, Acadia, Sarepta
Feb-10-17 10:17AM  Why Gilead's Disastrous Forecast is Good News for Biotech at
Feb-09-17 01:16PM  Leveraged ETFs: How Are They Built and What's Hot Now?
Feb-08-17 08:26AM  Oppenheimer: Currency FX on Rx at
Feb-05-17 09:47AM  5 reasons to bank on biotech stocks now at MarketWatch
Feb-03-17 04:49PM  The Week Ahead: Trump's 1st Quarter - Pain Or Gain? at Forbes
Feb-01-17 07:00AM  Trader's Daily Notebook: Post-Election Rally in Small-Caps Isn't Over Yet
Jan-31-17 05:28PM  Making pharma great again?
05:09PM  Stock Market Roundup Jan. 31: Nasdaq Rebounds Amid Trump Biotech Meeting
04:14PM  Wall Street Ends January on Weak Note as Washington Division Deepens
01:31PM  Volatile biotech trade illustrates Trumps ability to shift sentiment on a dime at MarketWatch
01:08PM  Biotech Stocks Gain on Latest Trump Drug Price Statements
10:57AM  President Trump Doubles Down On Healthcare Criticism, Says Drug Prices Are 'Astronomical'
10:37AM  Trump, at Biopharma Meeting, Pledges to 'Streamline' FDA, Cut Regulations but Wants Lower Prices
Jan-27-17 04:30PM  What Lies Ahead for Biotech ETFs in Trump Era?
Jan-26-17 01:21PM  Biotech ETFs: Is It Time To Buy? at
Jan-23-17 02:16PM  Top Biotech Stocks to Buy in 2017 at Motley Fool
Jan-18-17 10:03AM  4 Top Biotech Mutual Funds for 2017
06:00AM  Trump Foreshadows a Bleak Outlook for Biotech at Investopedia
Jan-17-17 11:16AM  Biotech ETFs: When Will The Pain End? at
Jan-16-17 10:55AM  Fidelity Biotech Fund: Better than the Index? at Motley Fool
Jan-12-17 12:01PM  Biotech ETFs Continue To Bleed at
12:00PM  Trump's First Press Conference Puts These ETFs in Focus
11:34AM  Trump's Remarks Show Why Pharma Sector Is 'Barely Investable': More Squawk From Jim Cramer
07:32AM  5 Things You Must Know Before the Market Opens Thursday
06:35AM  Donald Trump Whacks European Stocks
04:47AM  European Pharma Shares Hammered After Trump Press Conference Attack
Jan-11-17 04:27PM  Dow moves within 50 points of 20,000 after Trump news conference at MarketWatch
04:16PM  Nasdaq Posts Another Record Close in Unpredictable Trump-Triggered Trading Session
03:58PM  P.M. Funds Roundup: Mexico, Biotech ETFs Get Trumped; Is It RIP For Bitcoin ETF? at
03:16PM  Stocks Back to Gains in Unsettled Trade After Trump News Conference
02:36PM  Good Enough? Trump Outlines Plans to Separate From Business but Will Not Divest Holdings
02:14PM  Trump Takes Aim at Pharma but Investors Shouldn't Panic
12:31PM  Stocks Recover But Pharma Still Down After Trump's Threats at Forbes
12:09PM  Biotech, Pharma ETFs Sink; Trump Promises "Bidding Procedures" at
11:30AM  Biotech ETFs fall as Trump says more bidding needed on drugs at MarketWatch
Jan-09-17 09:06AM  How Was Incytes Profitability in 3Q16?
Jan-06-17 12:27PM  The 'Super Bowl' for health care investors
09:07AM  What Were Incytes Revenue Streams in 3Q16?
03:26AM  These stock-market sectors will be the most volatile in 2017: Goldman Sachs at MarketWatch
Jan-05-17 01:25PM  Biotech Stocks Find Reprieve in Options at The Wall Street Journal
Dec-29-16 07:36AM  United Therapeutics Robust Research Pipeline
Dec-28-16 07:02PM  Zacks Podcast Highlights: Immunotherapy Stocks 101: What Biotech Investors Need to Know Now
10:55AM  Celgene Winding Up for 2017 Breakout (CELG, IBB) at Investopedia
Dec-23-16 08:59AM  Your first trade for Friday, December 23 at CNBC
Dec-22-16 05:59PM  Final Trade: F, WTW & more
Dec-16-16 11:07AM  6 Best ETFs For When You're Both Bullish And Cautious About The Markets
Dec-14-16 10:18AM  These Charts Suggest Now Is the Time to Buy Biotech (SRPT) at Investopedia
06:33AM  How to play health care stocks under Trump: Pro
06:30AM  Can Trump keep promise to reduce drug prices?
Dec-12-16 07:32AM  Traders bet on floor in biotech fund
Dec-09-16 04:14PM  Biotech ETFs: A Short-Lived Boon From Biogen at
Dec-08-16 03:00PM  Biotech & Pharma ETFs to Suffer in 2017 Too?
11:27AM  3 Reasons To Shrug Off Trump's Rhetoric On Drug Prices at
10:44AM  Why Biotech is Getting KilledAnd Why It WIll Bounce Back at
Dec-07-16 05:00PM  Bad Day for Biotechs Means It's Time to Buy
04:28PM  Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Movers
04:06PM  Dow Scores Another Record for Third Consecutive Day; S&P 500 Also Hits New High
02:46PM  Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
02:11PM  President-elect Trumps promise to bring down drug prices sends biotech and pharma ETFs slumping at MarketWatch
01:40PM  Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower
12:40PM  Trumps Drug Price Comments Weigh on Biotech and Pharma ETFs and Shares at 24/7 Wall St.
11:35AM  This indicator says the stock markets celebration has gone too far at MarketWatch
11:31AM  Biotech ETFs: So Much For The Trump Bounce at
11:13AM  Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans
11:03AM  Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-Fall
09:14AM  Trump: I'm Going To Bring Down Drug Prices
08:49AM  President-elect Trump's biotech comments sharply lower biotech ETFs at MarketWatch
Dec-05-16 09:01AM  Here's Why ACADIA Pharmaceuticals Jumped 17.7% in November at Motley Fool
Dec-04-16 06:22PM  Billionaire Rob Citrones Monster Q3 Buys: Kellogg, Macys, Activision-Blizzard, More at Insider Monkey
Dec-02-16 09:21AM  3 Biotech Stocks to Buy in December at Motley Fool
08:44AM  Gundlach warns Trump trade is losing steam and stocks have peaked at MarketWatch
08:04AM  Label Expansion May Boost Venclextas Growth Prospects
08:04AM  What Do Analysts Recommend for Gilead Sciences Stock?
Dec-01-16 12:15PM  Nelson: Optimistic about innovation possibly impacting ca...
11:05AM  Valbenazine May Become a Leading Therapy for Tardive Dyskinesia
08:51AM  Five ways to evaluate an Obamacare replacement plan at MarketWatch
08:50AM  What to expect from HHS Secretary nominee and Obamacare opponent Tom Price at MarketWatch
08:06AM  Why AbbVie Wants to Develop Anti-Tau Therapies
Nov-29-16 05:04PM  Next-Generation Hepatitis C Therapy May Be AbbVies Growth Driver
02:00PM  AbbVies Financial Guidance for 2017
Nov-23-16 10:16AM  Analysts say Juno's stock tumbles shouldn't spill over to Bluebird, Kite Pharma shares at MarketWatch
Nov-22-16 10:08AM  How Stocks and Bonds Reacted to Trumps Victory
Nov-17-16 12:18PM  Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios
08:34AM  Leading Indicator, testing key breakout level!
Nov-16-16 05:22PM  Is Immunotherapy the Next Hot Industry for Biotech Stock Investors?
08:15AM  Biotech takes Trump presidency as a green light and end to drug price worries at MarketWatch
Nov-14-16 10:57AM  5 Reasons to Buy 5 Low P/E Biotech ETFs
Nov-13-16 11:20AM  Six Thoughts on President Trump and the Durability of the Biotech Stock Rally
Nov-11-16 05:05PM  November Surprise Rallies Stocks
Nov-10-16 11:26AM  The death of Obamacare will bring new opportunities for investors at MarketWatch
Nov-09-16 10:58AM  Here's Why Keryx Biopharmaceuticals Fell 18% in October at Motley Fool +10.37%
09:48AM  Drug and Biotech Stocks Rise as Price Clampdown Fears Ease Under Trump Presidency (Updated)
Nov-08-16 11:06AM  Investors Have Dumped Health-Care Stocks, Regardless of the Polls at The Wall Street Journal
09:34AM  Which S&P 500 Sectors Do the Best for an Incumbent Democrat?
Nov-07-16 01:22PM  Biotech ETFs Boosted By Biogen at
10:02AM  Healthcare ETFs in the Spotlight as Election Approaches
Nov-04-16 05:40PM  SPY ETF Tests A Key Level As Every S&P Sector Posts A Weekly Loss
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.